# LDAH

## Overview
LDAH, or Lipid Droplet-Associated Hydrolase, is a gene that encodes a protein involved in lipid metabolism, specifically within the context of lipid droplets in cells. The protein, also named LDAH, functions as a hydrolase, facilitating the breakdown of esterified sterols stored in lipid droplets, which is crucial for maintaining lipid homeostasis and regulating signaling pathways (Goo2024Lipid). LDAH is predominantly active in the cytoplasm, where it plays a significant role in mobilizing sterol lipids, including those that act as ligands for liver X receptors (LXRs), thereby influencing gene expression related to lipid metabolism and inflammatory responses (Goo2024Lipid). The gene has also been implicated in the pathogenesis of aggressive prostate cancer, as part of a gene signature associated with the disease, suggesting its potential involvement in cancer-related pathways (Mamidi2019Interactions).

## Function
Lipid Droplet-Associated Hydrolase (LDAH) is a protein involved in lipid metabolism, primarily associated with lipid droplets within cells. It plays a crucial role in the hydrolysis of esterified sterols, which are stored in lipid droplets, thereby influencing lipid homeostasis and signaling pathways (Goo2024Lipid). LDAH is active in the cytoplasm, particularly around lipid droplets, where it facilitates the mobilization of sterol lipids, including endogenous ligands for liver X receptors (LXRs) (Goo2024Lipid).

In healthy human cells, LDAH contributes to maintaining cellular lipid balance by promoting the hydrolysis of cholesterol esters and oxysterols, which are crucial for preventing lipid accumulation and maintaining energy homeostasis (Goo2024Lipid). The protein's activity influences the expression of genes involved in lipid metabolism and extracellular matrix homeostasis, such as ABCA1 and ABCG1, through an LXR-dependent mechanism (Goo2024Lipid). This regulatory function of LDAH is significant in modulating inflammatory responses and promoting a reparative macrophage phenotype, which is essential for maintaining tissue homeostasis and preventing pathological conditions like atherosclerosis (Goo2024Lipid).

## Clinical Significance
The LDAH gene, identified as part of a 61-gene signature associated with aggressive prostate cancer (PCa), has been linked to genetic variants that may contribute to the pathogenesis of this condition. The study by Mamidi et al. highlights the differential expression of LDAH and other genes between aggressive tumors and control samples, suggesting a potential role in the development of aggressive PCa (Mamidi2019Interactions). Although the specific clinical significance of LDAH mutations or expression changes in aggressive PCa is not detailed, its inclusion in the gene signature indicates its potential involvement in cancer-related pathways (Mamidi2019Interactions).

The research emphasizes the interactions between germline and somatic mutations in genes like LDAH, which are functionally related and interact within molecular networks and biological pathways. These interactions may occur through pathways such as MSP-RON signaling and P53 signaling, suggesting that LDAH could play a role in the molecular mechanisms driving aggressive PCa (Mamidi2019Interactions). The study proposes that understanding these interactions could inform the development of targeted therapeutics and precision prevention strategies for prostate cancer.


## References


[1. (Mamidi2019Interactions) Tarun Karthik Kumar Mamidi, Jiande Wu, and Chindo Hicks. Interactions between germline and somatic mutated genes in aggressive prostate cancer. Prostate Cancer, 2019:1â€“11, March 2019. URL: http://dx.doi.org/10.1155/2019/4047680, doi:10.1155/2019/4047680. This article has 10 citations.](https://doi.org/10.1155/2019/4047680)

[2. (Goo2024Lipid) Young-Hwa Goo, Janeesh Plakkal Ayyappan, Francis D. Cheeran, Sushant Bangru, Pradip K. Saha, Paula Baar, Sabine Schulz, Todd A. Lydic, Bernhard Spengler, Andreas H. Wagner, Auinash Kalsotra, Vijay K. Yechoor, and Antoni Paul. Lipid droplet-associated hydrolase mobilizes stores of liver x receptor sterol ligands and protects against atherosclerosis. Nature Communications, August 2024. URL: http://dx.doi.org/10.1038/s41467-024-50949-y, doi:10.1038/s41467-024-50949-y. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50949-y)